BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
BioAdaptives's free cash flow for the twelve months ending Dec 31, 2025 was -$534.03K. For fiscal 2025 it was -$534.03K.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$534.03K | – |
| FY2024 | Dec 31, 2024 | -$249.52K | – |
| FY2014 | Dec 31, 2014 | -$57.05K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$155.83K | – |
| Q3 FY2025 | Sep 30, 2025 | -$151.31K | – |
| Q4 FY2024 | Dec 31, 2024 | -$100.54K | – |
| Q3 FY2024 | Sep 30, 2024 | -$56.34K | – |
See a number that looks wrong?